| Date Filed | Type | Description |
| 04/28/2021 |
GN
| Advaxis to Present at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting |
| 04/26/2021 |
GN
| UPDATE - Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies |
| 04/26/2021 |
GN
| Advaxis Announces Receipt of Second Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies |
| 03/23/2021 |
GN
| Advaxis to Present Corporate Overview at the Benzinga Biotech Small Cap Conference |
| 03/16/2021 |
GN
| Advaxis Reports First Quarter Ended January 31, 2021 Financial Results and Provides a Business Update |
| 03/12/2021 |
GN
| Advaxis to Present at the American Association for Cancer Research (AACR) 2021 Annual Meeting |
| 01/25/2021 |
GN
| Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update |
| 01/19/2021 |
GN
| Advaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies |
| 12/22/2020 |
GN
| Advaxis Announces Listing Transfer to Nasdaq Capital Market and Additional 180-day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule |
| 11/23/2020 |
GN
| Advaxis, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock |
| 11/09/2020 |
GN
| Advaxis Presents Updated Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting |
| 09/24/2020 |
GN
| Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer |
| 09/10/2020 |
GN
| Advaxis Reports Third Quarter Ended July 31, 2020 Financial Results and Provides a Business Update |
| 09/04/2020 |
GN
| Advaxis Announces Resignation of Chief Financial Officer |
| 06/11/2020 |
GN
| Advaxis Reports Second Quarter Ended April 30, 2020 Financial Results and Provides a Business Update |
| 06/01/2020 |
GN
| Advaxis to Host Second Quarter Financial Results and Business Update Conference Call on Thursday, June 11, 2020 |
| 03/13/2020 |
GN
| Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update |
| 03/03/2020 |
GN
| Advaxis to Present at the 2020 LD Micro Virtual Conference |
| 02/27/2020 |
GN
| Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360° Conference |
| 01/30/2020 |
GN
| Data on Advaxis' Clinical Programs to be Presented at Upcoming Medical Meetings |
| 08/12/2019 |
GN
| BriaCell Appoints Richard J. Berman to Board of Directors |
| 04/03/2019 |
GN
| Market Trends Toward New Normal in The TJX Companies, Tronox, Service Corporation International, Southwest Gas, Advaxis, and International Seaways — Emerging Consolidated Expectations, Analyst Ratings |
| 10/18/2018 |
GN
| Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of Influence |
| 08/28/2018 |
GN
| Recent Analysis Shows Liberty TripAdvisor, Control4, Ferro, Advaxis, Frontier Communications, and Newpark Resources Market Influences — Renewed Outlook, Key Drivers of Growth |
| 03/12/2018 |
BW
| Advaxis Reports Fiscal 2018 First Quarter Financial Results and Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca's IMFINZI® (Durvalumab) |
| 03/09/2018 |
BW
| Advaxis to Host Business Update and First Quarter 2018 Financial Results Conference Call on March 12, 2018 |
| 12/20/2017 |
BW
| Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update |
| 12/14/2017 |
BW
| Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017 |
| 11/22/2017 |
GN
| Analysis: Positioning to Benefit within Diebold, Liberty TripAdvisor, Paycom Software, First American, Advaxis, and Sanmina — Research Highlights Growth, Revenue, and Consolidated Results |
| 09/21/2017 |
BW
| Advaxis to Webcast Company Overview at the Cantor Fitzgerald Global Healthcare Conference |
| 09/11/2017 |
BW
| Advaxis Reports Business Update and Third Quarter 2017 Results |
| 06/09/2017 |
BW
| Advaxis to Webcast Investor & Analyst Day 2017 |
| 06/08/2017 |
BW
| Update: Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare Conference Now Available |
| 04/19/2017 |
GN
| Advaxis Appoints Anthony Lombardo as Chief Business Officer |
|